Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis Detecting Circulating Tumor Cells

NCT02510781 is registered in ClinicalTrials.gov with Hospital Affiliated to Military Medical Science, Beijing as lead sponsor.

NCT NCT02510781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02510781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis Detecting Circulating Tumor Cells
Lead sponsor
Hospital Affiliated to Military Medical Science, Beijing
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2015
Completion date
December 31, 2017
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms